Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
Background. Convalescent plasma obtained from individuals who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains neutralizing antibodies to the virus and has been frequently used as a treatment in hospitalized patients with severe COVID-19. Methods. We conducte...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2022-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/7992927 |